Floatz logo

FLUOROURACILUM

Stage IV Colon Cancer

Sun Yat-sen UniversitySmall moleculePhase 3Active
BBB
77/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Stage IV Colon Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Sun Yat-sen University
Phase 3BBB
Irinotecan
Sun Yat-sen University
Phase 3BBB
(+)-VINCRISTINE
Gruppo Oncologico del Nord-Ovest
Phase 3BBB
Cediranib
National Cancer Institute (NCI)
Phase 2BB
Cetuximab
Merck Sharp & Dohme LLC
Phase 3BB

View all 41 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →